| The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Nature Biotechnology 28 (8), 827-38, 2010 | 847* | 2010 |
| Estimating the burden and economic impact of pediatric genetic disease N Gonzaludo, JW Belmont, VG Gainullin, RJ Taft Genetics in Medicine 21 (8), 1781-1789, 2019 | 79 | 2019 |
| Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors AJ Olaharski, N Gonzaludo, H Bitter, D Goldstein, S Kirchner, H Uppal, ... PLoS Computational Biology 5 (7), e1000446, 2009 | 71 | 2009 |
| Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data X Chen, F Shen, N Gonzaludo, A Malhotra, C Rogert, RJ Taft, DR Bentley, ... The pharmacogenomics journal 21 (2), 251-261, 2021 | 51 | 2021 |
| The MAQC-II Project: A comprehensive study of common practices for the development and validation of microarray-based predictive models. L Shi, G Campbell, W Jones, F Campagne, Z Wen, S Walker, Z Su, T Chu, ... Nature biotechnology 28 (8), 827-838, 2010 | 48 | 2010 |
| A meta-analysis of QTL for diabetes-related traits in rodents C Schmidt, NP Gonzaludo, S Strunk, S Dahm, J Schuchhardt, F Kleinjung, ... Physiological genomics 34 (1), 42-53, 2008 | 47 | 2008 |
| Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases D Incerti, XM Xu, JW Chou, N Gonzaludo, JW Belmont, BE Schroeder Genetics in Medicine 24 (1), 109-118, 2022 | 30 | 2022 |
| CYP2C8, CYP2C9, and CYP2C19 characterization using next-generation sequencing and haplotype analysis: a GeT-RM collaborative project A Gaedigk, EC Boone, SE Scherer, S Lee, I Numanagić, C Sahinalp, ... The Journal of Molecular Diagnostics 24 (4), 337-350, 2022 | 23 | 2022 |
| Consortium M. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models L Shi, G Campbell, WD Jones, F Campagne, Z Wen, SJ Walker, Z Su, ... Nat Biotechnol 28 (8), 827-838, 2010 | 22 | 2010 |
| PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing S L Rogers, NJ Keeling, J Giri, N Gonzaludo, JS Jones, E Glogowski, ... Pharmacogenomics 21 (11), 785-796, 2020 | 20 | 2020 |
| NO EVIDENCE OF DRUG RESISTANCE OR BASELINE S282T RESISTANCE MUTATION AMONG GT1 AND GT4 HCV INFECTED PATIENTS ON NUCLEOSIDE POLY-MERASE INHIBITOR RG7128 AND PEG-IFN/RBV … S Le Pogam, JM Yan, A Kosaka, Y Ji, N Gonzaludo, A Ewing, K Klumpp, ... Hepatology 52, 701A-702A, 2010 | 16 | 2010 |
| An efficient genotyper and star-allele caller for pharmacogenomics A Hari, Q Zhou, N Gonzaludo, J Harting, SA Scott, X Qin, S Scherer, ... Genome Research 33 (1), 61-70, 2023 | 12 | 2023 |
| Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors AJ Olaharski, H Bitter, N Gonzaludo, R Kondru, DM Goldstein, TS Zabka, ... Toxicological Sciences 118 (1), 266-275, 2010 | 12 | 2010 |
| The diagnostic trajectory of infants and children with clinical features of genetic disease BE Schroeder, N Gonzaludo, K Everson, KS Than, J Sullivan, RJ Taft, ... NPJ Genomic Medicine 6 (1), 98, 2021 | 8 | 2021 |
| Correction: Estimating the burden and economic impact of pediatric genetic disease N Gonzaludo, JW Belmont, VG Gainullin, RJ Taft Genetics in Medicine 21 (9), 2161, 2019 | 6 | 2019 |
| Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis KHY Wong, M Levy‐Sakin, W Ma, N Gonzaludo, ACY Mak, D Vaka, ... Molecular genetics & genomic medicine 7 (12), e1007, 2019 | 4 | 2019 |
| Prediction of cardiotoxicity HML Bitter, KL Kolaja, P Dhawan, H Uppal, N Gonzaludo US Patent App. 12/713,976, 2011 | 3 | 2011 |
| CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods N Null, S Jain, C Bakolitsa, SE Brenner, P Radivojac, J Moult, S Repo, ... Genome Biology 25 (1), 1-46, 2024 | 2 | 2024 |
| LOW RATE OF VIRAL LOAD REBOUND OBSERVED AMONG TREATMENT-NAIVE GENOTYPE 1 PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DANOPREVIR (RG7227) PLUS PEGIFN α-2A (40KD)(PEGASYS … S Le Pogam, M Chhabra, JM Yan, MJ Ilnicka, Y Ji, DJ Chin, N Gonzaludo, ... Hepatology 52, 703A-704A, 2010 | 2 | 2010 |
| Accurate CYP2D6 genotyping using whole genome sequencing data X Chen, F Shen, N Gonzaludo, A Malhotra, C Rogert, RJ Taft, DR Bentley, ... bioRxiv, 2020 | 1 | 2020 |
